Matinas Biopharma (MTNB) P/E (2014 - 2026)
Matinas Biopharma (MTNB) P/E from Aug 18, 2014 to Jul 21, 2026. The TTM Matinas Biopharma (MTNB) P/E is -0.15. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Matinas Biopharma (MTNB)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.15 | -51.48% |
| 2025 | -0.31 | +198.80% |
| 2024 | -0.10 | -95.36% |
| 2023 | -2.21 | -50.91% |
| 2022 | -4.50 | -51.31% |
| 2021 | -9.25 | -23.23% |
| 2020 | -12.05 | -40.21% |
| 2019 | -20.15 | +381.03% |
| 2018 | -4.19 | -41.65% |
| 2017 | -7.18 | -31.32% |
| 2016 | -10.45 | +108.81% |
| 2015 | -5.01 | +253.83% |
| 2014 | -1.41 | N/A |
Comparison Matinas Biopharma (MTNB) P/E with competitors
Matinas Biopharma (MTNB) P/E is -0.15.